9 Hrs
Source:
زاد الاردن
Intestinal compound linked to Alzheimer risk
The study reveals that a compound produced by a type of bacteria in the gut called "Imidazole Propionate" (ImP) increases the risk of Alzheimer's disease and accelerates cognitive decline in patients. Research has shown that elevated levels of this compound are associated with the accumulation of beta-amyloid and tau proteins in the brain, which are hallmark indicators of the disease. Additionally, a genetic variation that promotes its buildup further raises the likelihood of developing Alzheimer's. The study suggests that targeting this compound through the development of medications could reduce the risk of Alzheimer’s and slow the decline of cognitive functions. Although its source is an essential amino acid found in protein-rich foods—making avoidance challenging—this discovery opens the door to potential preventative treatments.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)